General Injectables and Vaccines (GIV) to market EZ Detect in US:
This article was originally published in Clinica
Executive Summary
General Injectables & Vaccines will market Biomerica's EZ Detect stool blood test to US physician hospitals, HMOs and nursing homes. The exclusive US marketing agreement is expected to generate sales of at least $4 million for Biomerica in the first three years. The two-minute home test is used to detect occult blood in the stool.